Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02463097 · ClinicalTrials.gov registry record · NA
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT02463097: Completed NA study, sponsored by Medtronic MiniMed.
NCT02463097 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02463097, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
This study is a single-arm, multi-center, Home and Hotel Clinical Investigation in subjects with type 1 diabetes on insulin pump therapy. The purpose of this study is to demonstrate that the closed loop algorithm that is built into the 670G insulin pump is safe as part of the overall system.
Interventions
- DEVICE Insulin Pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2015-06 |
| Est. Completion | 2018-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02463097
The ClinicalTrials.gov registry entry for NCT02463097 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin Pump is the first listed.
NCT02463097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02463097 about?
NCT02463097 is a clinical study titled "Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes". This study is a single-arm, multi-center, Home and Hotel Clinical Investigation in subjects with type 1 diabetes on insulin pump therapy. The purpose of this study is to demonstrate that the closed loop algorithm that is built into the 670G insulin pump is safe as part of the overall system.
What is the current status of trial NCT02463097?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2015-06. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02463097?
The interventions under investigation include: Insulin Pump (DEVICE).
Who is sponsoring clinical trial NCT02463097?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.